Cargando…

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport

Metformin is currently the most prescribed drug for treatment of type 2 diabetes mellitus in humans. It has been well established that long-term treatment with metformin improves glucose tolerance in mice by inhibiting hepatic gluconeogenesis. Interestingly, a single dose of orally administered metf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horakova, Olga, Kroupova, Petra, Bardova, Kristina, Buresova, Jana, Janovska, Petra, Kopecky, Jan, Rossmeisl, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468119/ https://www.ncbi.nlm.nih.gov/pubmed/30992489 http://dx.doi.org/10.1038/s41598-019-42531-0

Ejemplares similares

Reduced Number of Adipose Lineage and Endothelial Cells in Epididymal fat in Response to Omega-3 PUFA in Mice Fed High-Fat Diet
por: Adamcova, Katerina, et al.
Publicado: (2018)

Thermoneutral housing promotes hepatic steatosis in standard diet-fed C57BL/6N mice, with a less pronounced effect on NAFLD progression upon high-fat feeding
por: Horakova, Olga, et al.
Publicado: (2023)

Krill Oil Supplementation Reduces Exacerbated Hepatic Steatosis Induced by Thermoneutral Housing in Mice with Diet-Induced Obesity
por: Sistilli, Gabriella, et al.
Publicado: (2021)

Plasma Acylcarnitines and Amino Acid Levels As an Early Complex Biomarker of Propensity to High-Fat Diet-Induced Obesity in Mice
por: Horakova, Olga, et al.
Publicado: (2016)

Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: improvement of lipid metabolism
por: Veleba, Jiri, et al.
Publicado: (2015)

Additive Effects of Omega-3 Fatty Acids and Thiazolidinediones in Mice Fed a High-Fat Diet: Triacylglycerol/Fatty Acid Cycling in Adipose Tissue
por: Bardova, Kristina, et al.
Publicado: (2020)

A pyrexic effect of FGF21 independent of energy expenditure and UCP1
por: Zouhar, Petr, et al.
Publicado: (2021)

Omega-3 Phospholipids from Krill Oil Enhance Intestinal Fatty Acid Oxidation More Effectively than Omega-3 Triacylglycerols in High-Fat Diet-Fed Obese Mice
por: Kroupova, Petra, et al.
Publicado: (2020)

Adipose tissue-specific ablation of PGC-1β impairs thermogenesis in brown fat
por: Funda, Jiří, et al.
Publicado: (2022)

Impairment of adrenergically-regulated thermogenesis in brown fat of obesity-resistant mice is compensated by non-shivering thermogenesis in skeletal muscle
por: Janovska, Petra, et al.
Publicado: (2023)

Preservation of Metabolic Flexibility in Skeletal Muscle by a Combined Use of n-3 PUFA and Rosiglitazone in Dietary Obese Mice
por: Horakova, Olga, et al.
Publicado: (2012)

Unmasking Differential Effects of Rosiglitazone and Pioglitazone in the Combination Treatment with n-3 Fatty Acids in Mice Fed a High-Fat Diet
por: Kus, Vladimir, et al.
Publicado: (2011)

Effects of metformin on blood glucose levels and bodyweight mediated through intestinal effects
por: Harada, Norio
Publicado: (2020)

Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin
por: Janovska, Petra, et al.
Publicado: (2020)

Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation
por: Moonira, Tabassum, et al.
Publicado: (2020)

Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes
por: Zubiaga, Lorea, et al.
Publicado: (2023)

Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney
por: Harada, Norio, et al.
Publicado: (2012)

The Effect of Potassium on the Intestinal Transport of Glucose
por: Csáky, T. Z., et al.
Publicado: (1966)

Bio-enhancing Effect of Piperine with Metformin on Lowering Blood Glucose Level in Alloxan Induced Diabetic Mice
por: Atal, Shubham, et al.
Publicado: (2016)

Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production
por: Waise, T. M. Zaved, et al.
Publicado: (2019)

Glucose transporters in the small intestine in health and disease
por: Koepsell, Hermann
Publicado: (2020)

Effect of combined treatment with clozapine and metformin on fasting blood glucose, insulin level, and expression of the glucose transporter-2 (GLUT(2)) in Sprague-Dawley rats
por: Gao, Lan, et al.
Publicado: (2013)

Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones
por: Benova, Andrea, et al.
Publicado: (2022)

Sodium-dependent glucose transporter 1 and glucose transporter 2 mediate intestinal transport of quercetrin in Caco-2 cells
por: Li, Suyun, et al.
Publicado: (2020)

SAT031 The Effect Of Metformin On Increasing Glucose Metabolism And Secretion In The Distal Intestine
por: Ho Nam, Jung, et al.
Publicado: (2023)

Regulation of Glucose Insulinotropic Peptide and Intestinal Glucose Transporters in the Diet-Induced Obese Mouse
por: Rhodes, Ryon Sun, et al.
Publicado: (2022)

Effect of Hydrolyzable Tannins on Glucose-Transporter Expression and Their Bioavailability in Pig Small-Intestinal 3D Cell Model
por: Brus, Maksimiljan, et al.
Publicado: (2021)

Regulation of Intestinal Glucose Absorption by Ion Channels and Transporters
por: Chen, Lihong, et al.
Publicado: (2016)

Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma
por: Wang, Wei-Ming, et al.
Publicado: (2022)

Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
por: Garnett, James P, et al.
Publicado: (2013)

Induction of remission in diabetes by lowering blood glucose
por: Weir, Gordon C., et al.
Publicado: (2023)

Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients
por: te Brake, Lindsey H.M., et al.
Publicado: (2018)

Small Intestinal Glucose Transport : Proximal-Distal kinetic gradients
por: Rider, Alan K., et al.
Publicado: (1967)

Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
por: Ritsinger, Viveca, et al.
Publicado: (2020)

Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
por: Becker, Matthijs L., et al.
Publicado: (2009)

Effect of high glucose concentrations on human erythrocytes in vitro
por: Viskupicova, Jana, et al.
Publicado: (2015)

In Vitro and In Vivo Inhibition of Intestinal Glucose Transport by Guava (Psidium Guajava) Extracts
por: Müller, Ulrike, et al.
Publicado: (2018)

Lower fasting blood glucose in neurofibromatosis type 1
por: Martins, Aline Stangherlin, et al.
Publicado: (2015)

Plants Secondary Metabolites as Blood Glucose-Lowering Molecules
por: Shehadeh, Mayadah Bashir, et al.
Publicado: (2021)

Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
por: Marini, Cecilia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8s9nfjg9u0010092kcv5ka9fkh